Asymmetry Capital Management’s Tectonic Therapeutic TECX Stock Holding History
Bought
Maintained
Sold
Other funds holding TECX
EAM
FCM
CCM
SHI
ACM
Asymmetry Capital Management's TECX Position: Q2 2020 in Review
Asymmetry Capital Management sold out of Tectonic Therapeutic (TECX) in Q2 2020, closing a stake of 7,130 shares — an estimated $1.33M sold.
Asymmetry Capital Management first reported a position in TECX in Q1 2020 and held it in 1 quarter. The position peaked at $1.33M in Q1 2020. 98 funds tracked by Wall St. Rank hold TECX as of Q2 2020.
- Asymmetry Capital Management reported no remaining Tectonic Therapeutic position as of Q2 2020 after selling out during the quarter.
- Asymmetry Capital Management sold 7,130 Tectonic Therapeutic shares in Q2 2020, an estimated $1.33M.
- Asymmetry Capital Management first reported a position in Tectonic Therapeutic in Q1 2020 and held it in 1 quarter.
- Asymmetry Capital Management's Tectonic Therapeutic position peaked at $1.33M in Q1 2020.
- 98 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q2 2020.
Based on Asymmetry Capital Management's 13F filing for Q2 2020, filed 6 Aug 2020.